Literature DB >> 21515339

Junctions gone bad: claudins and loss of the barrier in cancer.

Kursad Turksen1, Tammy-Claire Troy.   

Abstract

The tight junctions (TJs) of epithelia are responsible for regulating the "fence and gate" function of polarized epithelial cells. It is now well-established that dysregulation of these functions contributes to initiation and progression of cancer. Recently, it has become clear that the Claudins, members of a large family of 27 closely related transmembrane proteins, play a crucial role in formation, integrity and function of TJs, the epithelial permeability barrier and epithelial polarization. A growing body of data indicates that Claudin expression is altered in numerous epithelial cancers in a stage- and tumor-specific manner. While a single universal mechanism is still lacking, accumulating evidence supports a role for epigenetic regulation of Claudin expression in tumorgenesis, with concomitant alterations in barrier function. We review here new insights and challenges in understanding Claudin function in normal physiology and cancer. 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21515339     DOI: 10.1016/j.bbcan.2011.04.001

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  59 in total

1.  Mechanism of Clostridium perfringens enterotoxin interaction with claudin-3/-4 protein suggests structural modifications of the toxin to target specific claudins.

Authors:  Anna Veshnyakova; Jörg Piontek; Jonas Protze; Negar Waziri; Ivonne Heise; Gerd Krause
Journal:  J Biol Chem       Date:  2011-11-28       Impact factor: 5.157

2.  The effects of pleiotrophin in proliferative vitreoretinopathy.

Authors:  Xue Ding; Yujing Bai; Xuemei Zhu; Tianqi Li; Enzhong Jin; Lvzhen Huang; Wenzhen Yu; Mingwei Zhao
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2017-01-12       Impact factor: 3.117

Review 3.  Claudins and the modulation of tight junction permeability.

Authors:  Dorothee Günzel; Alan S L Yu
Journal:  Physiol Rev       Date:  2013-04       Impact factor: 37.312

4.  HGF signaling regulates Claudin-3 dynamics through its C-terminal tyrosine residues.

Authors:  Floor Twiss; Michiel Oldenkamp; Annemieke Hiemstra; Houjiang Zhou; Lucrèce Matheron; Shabaz Mohammed; Johan de Rooij
Journal:  Tissue Barriers       Date:  2014-01-09

5.  Directed structural modification of Clostridium perfringens enterotoxin to enhance binding to claudin-5.

Authors:  Jonas Protze; Miriam Eichner; Anna Piontek; Stefan Dinter; Jan Rossa; Kinga Grażyna Blecharz; Peter Vajkoczy; Joerg Piontek; Gerd Krause
Journal:  Cell Mol Life Sci       Date:  2014-10-24       Impact factor: 9.261

6.  Junctional adhesion molecules 2 and 3 may potentially be involved in progression of gastric adenocarcinoma tumors.

Authors:  Mohammadreza Hajjari; Mehrdad Behmanesh; Majid Sadeghizadeh; Mehdi Zeinoddini
Journal:  Med Oncol       Date:  2013-01-01       Impact factor: 3.064

7.  Methods to examine tight junction physiology in cancer stem cells: TEER, paracellular permeability, and dilution potential measurements.

Authors:  Michael Buchert; Kursad Turksen; Frédéric Hollande
Journal:  Stem Cell Rev Rep       Date:  2012-09       Impact factor: 5.739

8.  Expression changes of cell-cell adhesion-related genes in colorectal tumors.

Authors:  Mateusz Bujko; Paulina Kober; Michal Mikula; Marcin Ligaj; Jerzy Ostrowski; Janusz Aleksander Siedlecki
Journal:  Oncol Lett       Date:  2015-04-08       Impact factor: 2.967

9.  Tricellulin expression and its prognostic significance in primary liver carcinomas.

Authors:  Aron Somorácz; Anna Korompay; Péter Törzsök; Attila Patonai; Boglárka Erdélyi-Belle; Gábor Lotz; Zsuzsa Schaff; András Kiss
Journal:  Pathol Oncol Res       Date:  2014-03-21       Impact factor: 3.201

10.  Claudins 1, 2, 3, 4, 5 and 7 in solar keratosis and squamocellular carcinoma of the skin.

Authors:  Hanna-Riikka Hintsala; Maria Siponen; Kirsi-Maria Haapasaari; Peeter Karihtala; Ylermi Soini
Journal:  Int J Clin Exp Pathol       Date:  2013-11-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.